A 10-year survey of Mycobacterium tuberculosis isolates in Pavia and their drug resistance: A comparison with other Italian reports

Journal of Chemotherapy

Volumn 14, Issue 1, 2002, Pages 33-40

  Fietta, Anna ^a   Cascina, A ^a   Meloni, F ^a   Morosini, M ^a   Casali, L ^a   Bono, L ^a   Minoli, L ^a   Marone, P ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

First line antituberculosis drugs, combined resistance, primary resistance, acquired resistance, tuberculosis resistance.; Mycobacterium tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; ITALY; LUNG TUBERCULOSIS; MEDICAL RECORD; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RETROSPECTIVE STUDY;

EID: 0036196034     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2002.14.1.33     Document Type: Article

References (41)

1. Assessment of worldwide tuberculosis control
2. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country
3. Adult tuberculosis overview: African versus Western perspectives
4. Dynamics and control of the global tuberculosis epidemic
5. st century
6. Nationwide survey of drug-resistant tuberculosis in the United States
7. Outcome of multidrug-resistant tuberculosis in human imunodeficiency virus-infected patients
8. Drug-resistant tuberculosis
9. Molecular determinats of drug resistance in tuberculosis
10. Antimicrobial agent resistance in mycobacteria: Molecular genetic insights
11. Global trends in resistance to antituberculosis drugs
12. Mycobacteria: Laboratory methods for testing drug sensitivity and resistance
13. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programs
14. New Agar medium for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide
15. Rifampicin a new orally active rifamycine
16. Criteria for the control of drug-resistant tuberculosis
17. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis
18. Improved outcomes for patients with multidrug-resistant tuberculosis
19. Standard short-course chemotherapy for drug-resistant tuberculosis: Treatment outcomes in 6 countries
20. Database study of antibiotic resistant tuberculosis in the United Kingdom, 1994-6
21. Prevalence of drug resistance to antituberculosis drugs in immigrants and HIV positive cases in Italy
22. Epidemiology and ethnic distribution of multidrug-resistant tuberculosis in southern Israel, 1992-1997: The impact of immigration
23. Tuberculosis among immigrants from developing countries in the province of Milan, 1993-1996
24. Drug-resistant and multidrug-resistant tubercle bacilli
25. The impact of drug resistance on the global tuberculosis epidemic
26. Drug resistance patterns among tuberculosis patients in Rome, 1990-1992
27. Multidrug-resistant tuberculosis in the Florence province from 1992 to 1995
28. The threat of multidrug-resistant tuberculosis: Results of 1 yr of surveillance in the Lombardy region of Italy
29. The Italian AIPO study on tuberculosis treatment results, report 1995
30. The Italian AIPO study on tuberculosis treatment results, report 1996
31. The Italian AIPO study on tuberculosis treatment results, report 1997
32. Evaluation of tuberculosis treatment results in Italy, report 1998
33. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection
34. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment
35. Risk factors for rifampin-monoresistant tuberculosis: A case-control study
36. Bacteriological and molecular analysis of rifampin-resistant Mycobacterium tuberculosis strains isolated in Australia
37. Risk factors for rifampin mono-resistant tuberculosis
38. Rifampin-monoresistant tuberculosis in New York City, 1993-1994
39. An outbreak of multidrug-resistant tuberculosis involving HlV-infected patients of two hospital in Milan, Italy